Healthcare provider profile · identity verified

Dipesh B Patel, MD

Family Practice · PORT ST. LUCIE, FL · NPI 1093942682

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	890	261
Rosuvastatin Calcium	Rosuvastatin Calcium	861	268
Levothyroxine Sodium	Levothyroxine Sodium	804	229
Atorvastatin Calcium	Atorvastatin Calcium	689	208
Losartan Potassium	Losartan Potassium	570	175
Lisinopril	Lisinopril	563	156
Omeprazole	Omeprazole	472	161
Metformin Hcl	Metformin Hcl	437	133
Alprazolam	Alprazolam	383	112
Simvastatin	Simvastatin	377	109
Hydrochlorothiazide	Hydrochlorothiazide	373	112
Montelukast Sodium	Montelukast Sodium	328	109
Tamsulosin Hcl	Tamsulosin Hcl	308	94
Metoprolol Succinate	Metoprolol Succinate	288	86
Methylprednisolone	Methylprednisolone	286	249
Sertraline Hcl	Sertraline Hcl	275	82
Pantoprazole Sodium	Pantoprazole Sodium	263	88
Metoprolol Tartrate	Metoprolol Tartrate	242	71
Albuterol Sulfate Hfa	Albuterol Sulfate	241	123
Zolpidem Tartrate	Zolpidem Tartrate	215	46
Meloxicam	Meloxicam	185	53
Fluticasone Propionate	Fluticasone Propionate	178	84
Furosemide	Furosemide	175	76
Pravastatin Sodium	Pravastatin Sodium	164	49
Allopurinol	Allopurinol	162	55
Escitalopram Oxalate	Escitalopram Oxalate	162	51
Clonazepam	Clonazepam	151	34
Gabapentin	Gabapentin	147	52
Clopidogrel	Clopidogrel Bisulfate	146	43
Glipizide	Glipizide	133	44
Potassium Chloride	Potassium Chloride	133	50
Ezetimibe	Ezetimibe	129	39
Trazodone Hcl	Trazodone Hcl	127	44
Lorazepam	Lorazepam	124	34
Carvedilol	Carvedilol	121	40
Azithromycin	Azithromycin	112	105
Famotidine	Famotidine	112	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	112	29
Januvia	Sitagliptin Phosphate	108	35
Synthroid	Levothyroxine Sodium	106	29
Citalopram Hbr	Citalopram Hydrobromide	103	34
Ozempic	Semaglutide	100	30
Eliquis	Apixaban	95	28
Atenolol	Atenolol	94	29
Diazepam	Diazepam	90	36
Temazepam	Temazepam	88	26
Tramadol Hcl	Tramadol Hcl	83	28
Fenofibrate	Fenofibrate	80	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	79	53
Glimepiride	Glimepiride	73	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	73	20
Finasteride	Finasteride	69	23
Venlafaxine Hcl Er	Venlafaxine Hcl	69	22
Cephalexin	Cephalexin	66	55
Lovastatin	Lovastatin	66	19
Esomeprazole Magnesium	Esomeprazole Magnesium	65	17
Doxycycline Hyclate	Doxycycline Hyclate	64	58
Breo Ellipta	Fluticasone/Vilanterol	61	23
Meclizine Hcl	Meclizine Hcl	61	39
Vitamin D2	Ergocalciferol (Vitamin D2)	60	29
Dicyclomine Hcl	Dicyclomine Hcl	58	34
Valsartan	Valsartan	57	19
Alendronate Sodium	Alendronate Sodium	50	15
Diclofenac Sodium	Diclofenac Sodium	50	26
Fluoxetine Hcl	Fluoxetine Hcl	50	15
Paroxetine Hcl	Paroxetine Hcl	49	16
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	48	37
Bupropion Xl	Bupropion Hcl	47	16
Celecoxib	Celecoxib	47	12
Jardiance	Empagliflozin	47	14
Trulicity	Dulaglutide	45	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	14
Ibuprofen	Ibuprofen	43	15
Dropsafe Prep Pads	Alcohol Antiseptic Pads	42	12
Duloxetine Hcl	Duloxetine Hcl	42	18
Tizanidine Hcl	Tizanidine Hcl	42	11
Amoxicillin	Amoxicillin	41	35
Ramipril	Ramipril	41	12
Olmesartan Medoxomil	Olmesartan Medoxomil	40	13
Hydralazine Hcl	Hydralazine Hcl	39	14
Clonidine Hcl	Clonidine Hcl	38	14
Valacyclovir	Valacyclovir Hcl	36	18
Buspirone Hcl	Buspirone Hcl	35	12
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Metformin Hcl Er	Metformin Hcl	34	11
Myrbetriq	Mirabegron	34	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	31
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	33	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Tradjenta	Linagliptin	32	suppressed
Verapamil Er	Verapamil Hcl	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Farxiga	Dapagliflozin Propanediol	29	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Gemfibrozil	Gemfibrozil	28	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Hydrocortisone	Hydrocortisone	27	15
Lansoprazole	Lansoprazole	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Spironolactone	Spironolactone	26	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	21
Estradiol	Estradiol	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	11
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	15
Ondansetron Odt	Ondansetron	21	17
Benazepril Hcl	Benazepril Hcl	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	20
Levofloxacin	Levofloxacin	20	16
Clobetasol Propionate	Clobetasol Propionate	18	12
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Liothyronine Sodium	Liothyronine Sodium	18	suppressed
Naproxen	Naproxen	18	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Ibu	Ibuprofen	15	suppressed
Prednisone	Prednisone	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	14	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Baclofen	Baclofen	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Olanzapine-Fluoxetine Hcl	Olanzapine/Fluoxetine Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Fluconazole	Fluconazole	11	11
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Norvasc	Amlodipine Besylate	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error